Shanghai Fosun Pharmaceutical’s SBK010 Stroke Treatment Accepted for NMPA Review
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company based...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company based...
Shenzhen-based vascular intervention specialist OrbusNeich Medical Group Ltd (HKG: 6929) has announced a significant distribution...
HONG KONG—Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has announced that it has received Breakthrough...
BEIJING—Baheal Pharmaceutical Group, a leading healthcare services and distribution company in China, is venturing into...
The National Healthcare Security Administration (NHSA) has reported that 12 device manufacturers, both domestic and...
SINGAPORE—In a strategic move to strengthen its position in the global medical device market, Edwards...
Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003), a leading provider of cardiovascular disease solutions...
Lepu Scientech Medical Technology (Shanghai) Co., Ltd. (HKG: 2291) has announced that it has received...
Sino Medical Sciences Technology Inc. (SHA: 688108), a prominent player in China’s medical device sector,...
Shanghai Artech Medical Technology Co., Ltd., a company known for its innovation in the medical...
Innovent Biologics Inc. (HKG: 1801), a leading biopharmaceutical company based in China, in collaboration with...
Shanghai-based medical device conglomerate MicroPort Scientific Corp. (HKG: 0853) has announced that it has received...
Shanghai-based medical device titan MicroPort Scientific Corp. (HKG: 0853) has announced that it has received...
Beijing Balance Medical Technology Co., Ltd (SHA: 688198), a leading medical technology firm based in...
Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016), a leading player in the medical technology...
Lepu Scientech Medical Technology (Shanghai) Co., Ltd (HKG: 2291), a leading medical technology company based...
China-based Peijia Medical Ltd (HKG: 9996) has announced that its US-based partner JenaValve Technology Inc....
Novo Nordisk (NYSE: NVO)’s anti-obesity drug Wegovy (semaglutide) has received a new indication approval in...
Rona Therapeutics, a Shanghai-based nucleic acid drug developer, has secured USD 35 million in a...
Suzhou Sanegene Bio Inc., a leading RNAi specialist with research and development centers in both...